Munich Re
Provides reinsurance and specialty insurance solutions globally, alongside the ERGO brand's direct insurance products for life, health, and property-casualty coverage.
As of Aug 31, 2026
Summary
Munich Re is a global reinsurance and insurance group providing risk solutions and underwriting capacity across multiple lines of business. The stock trades with a neutral technical bias at €518.00 per share, having shown modest gains today but flat performance over the past year. The company carries a market capitalisation of €65.2 billion, reflecting its position as one of the world's largest reinsurers.
Price history
As of Aug 28, 2026
Performance
+0.15%
+0.31%
-0.92%
+17.09%
-3.46%
-0.34%
As of Aug 28, 2026
Technical indicators
- 54.3
- -0.9Bearish
- 50: 508.17 · 200: 504.5Bullish
- €507.80 / €520.40
Technical Bias
Munich Re's technical setup presents a split signal. The 50-day moving average sits above the 200-day line, which typically suggests upward momentum, while the MACD indicator is showing weakness in the near term. The RSI sits near its midpoint, offering no clear directional tilt. This is a derived technical read showing neutral overall bias, not a recommendation.
A transparent read of the indicators below — not a prediction or recommendation.
As of Aug 28, 2026
Fundamentals
- €65.2B
- 9.64
- €53.75
- 11.16%
- +1.3%
- €1.10B
- 0.33
- €437.40 – €549.37
- 4.67%
- Apr 30, 2026
- Nov 12, 2026 (72 days)
As of Aug 31, 2026
Upcoming catalysts
- Earnings report
As of Aug 31, 2026
Latest news
As of Aug 31, 2026
MonkeyTrade's Take on Munich Re
Short-term outlook
Munich Re's short-term setup leans mildly bullish but far from decisive: the 50 and 200-day averages both sit just under price, giving underlying support, yet MACD's bearish tilt and a flat RSI of 54.3 show momentum has stalled, consistent with the 1-month dip of 0.9%. A break above €520.40 would confirm the bullish case, while a slip through €507.80 support would tip things bearish. No earnings catalyst is imminent, with the next report not due until November 2026.
Medium-term outlook
Munich Re's numbers tell a story of solid, unglamorous value: a 9.64 P/E, 11.2% margins and a 4.7% dividend yield suggest the market is pricing in little growth despite the business staying profitable. With revenue growth barely ticking up at 1.3% and the technical picture flat, the next few quarters look like a holding pattern rather than a breakout. A pickup in premium growth would be the trigger that shifts this from steady-income play to something more compelling.
Key risks
- Revenue growth of just 1.3% year on year is modest, and a slowdown here could weigh on sentiment given the stock trades close to the top of its 52-week range.
- Munich Re's large long-term care reinsurance deal with Manulife, worth $3.2 billion, adds long-duration liability exposure that can be sensitive to changes in mortality, morbidity, and interest rate assumptions over time.
- As a reinsurer, profitability is tied to claims experience and catastrophe losses, which can be volatile and are not fully visible in current margin figures.
- With a low beta of 0.33, the stock tends to move independently of broader markets, which means company-specific developments, such as reinsurance treaty performance, may have an outsized effect on the share price relative to market-wide swings.
About Munich Re
Munich Re is one of the world's largest reinsurance companies, providing cover to primary insurers against large-scale and complex risks. Listed on Xetra under the ticker MUV2, it sits within the financial services sector, specifically the reinsurance industry, where scale and underwriting discipline are key competitive advantages. With a market capitalisation of €65.2 billion, it ranks among the more significant names in European insurance.
The company's key figures point to a business valued conservatively relative to its earnings, with a price-to-earnings ratio of 9.64, and one that returns a meaningful portion of profit to shareholders, reflected in a dividend yield of +4.7%. Together, these metrics offer a snapshot of a mature, established insurer generating steady earnings within a capital-intensive, cyclical industry.
How to trade Munich Re
Shares like this are usually traded as CFDs. Compare regulated brokers that offer share CFDs — weigh spreads, fees and platforms before you open an account.
AI-assisted research for informational purposes only — not investment advice. Figures are sourced from third-party market data and may be delayed. Do your own research before trading. Your capital is at risk. How we build these pages.